| Not Yet Recruiting | Bioequivalence Study of Liquid Metformin (100 and 250 mg/mL) vs IR Tablets NCT07300033 | Aspargo Labs, Inc | Phase 1 |
| Not Yet Recruiting | A First in Human Study to Assess Safety, Tolerability and Pharmacokinetics of a Single Dose of REGN22044 in He NCT07526116 | Regeneron Pharmaceuticals | Phase 1 |
| Not Yet Recruiting | First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Derm NCT07527923 | Regeneron Pharmaceuticals | Phase 1 |
| Not Yet Recruiting | Safety Study of Intravenous Hydrogen-Oxygen Ultrafine Bubbles in Adults NCT07357909 | Yayasan Inovasi Molekuler Indonesia (Indonesia Molecular Innovation Foundation) | Phase 1 |
| Recruiting | Early Metabolic Effects of Antiretroviral Drugs in Healthy volUnteers: a Phase 2 Randomized Study NCT05652478 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Recruiting | Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized T NCT06274749 | National Institute on Aging (NIA) | N/A |
| Not Yet Recruiting | Effects of Meal Macronutrients on Postprandial Lipids NCT07313787 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Not Yet Recruiting | Assessing the Impact of Perceptions of Unpredictability on Objective Measures of Food Consumption and Metaboli NCT06690294 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | — |
| Not Yet Recruiting | PK and Relative Bioavailability of Novel Liquid Metformin vs Tablets NCT07300020 | Aspargo Labs, Inc | Phase 1 |
| Recruiting | A Safety and Pharmacokinetics Study of TL-001 in Healthy Adults and Open-label Assessments in Participants Wit NCT07526519 | TrueLab Biopharmaceutical Co., Ltd | Phase 1 |
| Not Yet Recruiting | Pharmacokinetics of Antituberculosis Drugs in Breastfeeding Women NCT07069582 | McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 1 |
| Recruiting | Safety and Tolerability Trial of Psilocybin in Healthy Older Adults NCT07516405 | University of Colorado, Denver | Phase 1 |
| Recruiting | A Study to Assess Adverse Events, Tolerability, and Pharmacokinetics of Subcutaneous Injections of ABBV-295 in NCT07514260 | AbbVie | Phase 1 |
| Recruiting | Combining Motor Imagery and Tendon Vibration on the Effectiveness of Motor Imagery NCT06845176 | Centre Hospitalier Universitaire de Saint Etienne | N/A |
| Recruiting | A Phase 1 Study to Assess the Effect of ABBV-722 on Ethinyl Estradiol and Levonorgestrel Drug Levels in Health NCT07502417 | AbbVie | Phase 1 |
| Recruiting | Study of TRX-100 Tablets Evaluating the Safety, Pharmacokinetics, and Food Effect in Healthy Volunteers NCT07526506 | Traws Pharma, Inc. | Phase 1 |
| Not Yet Recruiting | Women's Heart: Impact of Ultra-endurance and Hormonal Profile on Cardiac and Systemic Inflammatory Parameters NCT07372859 | French Cardiology Society | N/A |
| Recruiting | Single Ascending Dose Study of HB2198 in Healthy Participants NCT07439263 | Hinge Bio | Phase 1 |
| Not Yet Recruiting | PK and Relative Bioavailability of Liquid Metformin vs Tablets in Healthy Adults NCT07300007 | Aspargo Labs, Inc | Phase 1 |
| Recruiting | Impact of Exogenous Ketones on Breathing in Healthy Volunteers NCT07220122 | Johns Hopkins University | EARLY_Phase 1 |
| Not Yet Recruiting | A Study to Assess How Intravenous and Subcutaneous Administrations of Risankizumab Moves Through the Body of H NCT07466550 | AbbVie | Phase 1 |
| Not Yet Recruiting | Catequentinib Hydrochloride (AL3818) Drug-Drug Interaction Study in Healthy Volunteers NCT07438886 | Advenchen Laboratories Nanjing Ltd. | Phase 1 |
| Recruiting | A Phase 1 Study of the Safety and How the Body Processes ABBV-722 and Upadacitinib After Multiple Oral Doses i NCT07425899 | AbbVie | Phase 1 |
| Recruiting | A Study to Assess How the Body Absorbs ABBV-8736 Subcutaneous Injections Relative to Intravenous Injections in NCT07413133 | AbbVie | Phase 1 |
| Recruiting | A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Wom NCT07414784 | AbbVie | Phase 1 |
| Recruiting | A Study to Learn How Fluconazole, Carbamazepine and Itraconazole Affect How the Body Processes ASP3082 in Heal NCT07395024 | Astellas Pharma Global Development, Inc. | Phase 1 |
| Recruiting | Evaluation of Single Dosing With Two F/TAF Tablets Among Healthy Volunteers NCT07349758 | Johns Hopkins University | Phase 1 |
| Not Yet Recruiting | Augmenting Existing Normative Data for QbMobile in Healthy Children Aged 6-11 Years NCT07330960 | Qbtech AB | — |
| Not Yet Recruiting | A Study to Evaluate the Pharmacokinetics and Food-effect of IN-M00002 Tablet in Healthy Adult Volunteers NCT07277712 | HK inno.N Corporation | Phase 1 |
| Recruiting | Dysautonomia in Children With Type 1 Diabetes NCT07455994 | Centre Hospitalier Universitaire de Saint Etienne | N/A |
| Completed | Gastric Emptying With Trou Normand NCT06728761 | Hospices Civils de Lyon | N/A |
| Recruiting | Power Nap With TES-TI NCT07090135 | University of Wisconsin, Madison | N/A |
| Recruiting | A Study to Learn More About the Safety of BIIB145 and How it is Processed in the Body of Healthy Adult Partici NCT07225517 | Biogen | Phase 1 |
| Enrolling By Invitation | Ultralow Dose PET Imaging of 18F-flurpiridaz NCT07284576 | Akiva Mintz | Phase 2 |
| Not Yet Recruiting | Turkish Validity and Reliability of VRSUQ NCT07247747 | Abant Izzet Baysal University | — |
| Recruiting | A Study to Learn How the Body Processes BIIB141 (Omaveloxolone) When Taken as a Capsule or as a Tablet Dissolv NCT07297199 | Biogen | Phase 1 |
| Recruiting | Evaluation of the Comfort Increase Provided by an Additional Foam Pad on a Lumbar Belt and Its Biophysical Imp NCT07355790 | Centre Hospitalier Universitaire de Saint Etienne | N/A |
| Recruiting | Healthy Volunteer Study NCT07270783 | InventisBio Co., Ltd | Phase 1 |
| Not Yet Recruiting | Improving Healing in Children After Tooth Extraction Using Laser Therapy or Hyaluronic Acid NCT07205640 | Cairo University | N/A |
| Recruiting | A Research Study of a New Medicine, NNC9733-0001, in Healthy Participants and Participants With Type 2 Diabete NCT07270731 | Novo Nordisk A/S | Phase 1 |
| Recruiting | A Study to Compare Blood Levels of Different Dosage Formulations of the Study Medicine That Is a CGRP Receptor NCT07261371 | Pfizer | Phase 1 |
| Recruiting | A Study to Evaluate How the Study Drug Moves Through the Body, Adverse Events, and How the Body Tolerates ABBV NCT07232004 | AbbVie | Phase 1 |
| Recruiting | A Study to Assess the Adverse Events and How Oral ABBV-1042 Moves Through the Body of Healthy Adult Participan NCT07222709 | AbbVie | Phase 1 |
| Completed | A Study to Assess the Mass Balance of Oral ABBV-1354 in Healthy Adult Male Participants NCT07219017 | AbbVie | Phase 1 |
| Not Yet Recruiting | A Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male Participants NCT06953934 | AbbVie | Phase 1 |
| Recruiting | A First-in-Human Single and Multiple Ascending Dose Study of MT-201 NCT07219368 | Mirador Therapeutics, Inc. | Phase 1 |
| Recruiting | Study About Whether Atirmociclib/PF-07220060 Proportionally Increases Exposure as Dose Increases in Healthy Pa NCT07215078 | Pfizer | Phase 1 |
| Recruiting | A Study to Assess the Adverse Events and How Oral Emraclidine Moves Through the Body of Healthy Elderly Adult NCT07219030 | AbbVie | Phase 1 |
| Recruiting | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PN-881 in Healthy Subjects. NCT07153146 | Protagonist Therapeutics, Inc. | Phase 1 |
| Recruiting | Randomized, Open-label, Safety Study of Subcutaneous and Intramuscular Injections of Niagen® Plus NCT07251608 | ChromaDex, Inc. | Phase 1 |
| Completed | A Clinical Study to See How the Body Handles and How Safe a Combination Tablet of Gemigliptin, Dapagliflozin, NCT07333742 | LG Chem | Phase 1 |
| Recruiting | Comparison of DW-1021 and Separate Doses of Pelubi CR and Zytram CR Under Fasting Conditions NCT07032558 | Haiphong University of Medicine and Pharmacy | Phase 1 |
| Completed | Food Effect Study in Healthy Volunteers NCT07254286 | Biomea Fusion Inc. | Phase 1 |
| Recruiting | Study of Visual Perception Phenomena: Phosphene Mapping Induced by TMS and Its Relationship With Eye Movements NCT07110493 | Skolkovo Institute of Science and Technology | N/A |
| Active Not Recruiting | A Study to Evaluate Adverse Events, How the Drug is Tolerated, and How the Drug Moves Through the Body of Intr NCT07141199 | AbbVie | Phase 1 |
| Completed | A Study to Learn if Taking BIIB141 (Omaveloxolone) Affects How Omeprazole is Processed in the Body and About B NCT07149415 | Biogen | Phase 1 |
| Not Yet Recruiting | Sucralose as a Way to Enhance Regulatory T Cells NCT06997133 | Caroline Lamarche | N/A |
| Completed | Motivation While Doing Physical Exercise in a Social Dual-task Virtual Environment NCT07050654 | Istituto di Sistemi e Tecnologie Industriali Intelligenti per il Manifatturiero Avanzato | N/A |
| Recruiting | Ultralow Dose PET Imaging for 18F-NaF Uptake NCT07284563 | Akiva Mintz | Phase 2 |
| Not Yet Recruiting | Single Oral Dose Comparative Bioavailability Study of Investigational Product in Healthy Human Subjects Under NCT07141368 | Vedic Lifesciences Pvt. Ltd. | N/A |
| Recruiting | A Study to Learn About the Safety of BIIB142 and How it is Processed in the Body of Healthy Adult Participants NCT07133828 | Biogen | Phase 1 |
| Completed | Study to Assess the Adverse Events, Tolerability, and How Oral Doses of ABBV-932 Moves Through the Body in Hea NCT07024797 | AbbVie | Phase 1 |
| Completed | A Study Assessing Brain Activity, Safety, Tolerability, and Pharmacokinetics Following Multiple Doses of MLS10 NCT07050368 | MycoMedica Life Sciences PBC | Phase 1 |
| Completed | Psychedelic Virtual Reality NCT06581263 | Yale University | — |
| Active Not Recruiting | A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazol NCT07071532 | AbbVie | Phase 1 |
| Active Not Recruiting | Comparison of Pharmacokinetic Responses to Three Ketone Esters NCT07289165 | NeuroEnergy Ventures, Inc. | N/A |
| Completed | CaroRite™ for Skin Health and Signs of Ageing NCT06878001 | RDC Clinical Pty Ltd | Phase 4 |
| Recruiting | Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Dia NCT06609356 | Vanderbilt University Medical Center | EARLY_Phase 1 |
| Recruiting | Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in H NCT07051629 | Suninflam Inc | Phase 1 |
| Completed | A Study to Learn How BIIB141 (Omaveloxolone) is Processed in the Body When Taken as Capsules Compared to Sprin NCT07019064 | Biogen | Phase 1 |
| Active Not Recruiting | A Phase 1 Study of Mosliciguat in Healthy, Adult Males NCT07185321 | Pulmovant, Inc. | Phase 1 |
| Recruiting | Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors NCT06819189 | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Phase 1 |
| Active Not Recruiting | MRI Assessment of Knee Kinematics From Extension to Flexion - Exploratory Study NCT07016906 | GCS Ramsay Santé pour l'Enseignement et la Recherche | N/A |
| Recruiting | Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease NCT06989320 | University of Alabama at Birmingham | N/A |
| Recruiting | Ultralow Dose PET Imaging for PSMA Expression NCT06904313 | Akiva Mintz | Phase 2 |
| Recruiting | Ultralow Dose PET Imaging of 18F-FDG Uptake NCT06956391 | Akiva Mintz | Phase 2 |
| Recruiting | A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis NCT07038720 | Usynova Pharmaceuticals Ltd. | Phase 1 |
| Completed | A Study to Assess Drug Levels, Tolerability and Absolute Biological Availability of Single-dose of BMS-986446 NCT06955741 | Bristol-Myers Squibb | Phase 1 |
| Completed | LC-Plasma on Immune Response and Reducing Symptoms of Upper Respiratory Infectious Diseases NCT06837961 | RDC Clinical Pty Ltd | Phase 3 |
| Completed | A Study to Assess the Relative Bioavailability of Risankizumab Following Subcutaneous Administration With On-B NCT06937619 | AbbVie | Phase 1 |
| Completed | Bioequivalence Study betweenYHP2407 and YHR2502 in Healthy Subjects NCT06926387 | Yuhan Corporation | Phase 1 |
| Recruiting | First-In-Human Study to Evaluate Single and Multiple Ascending Doses of JUV-161 in Healthy Adult Volunteers NCT06918925 | Juvena Therapeutics | Phase 1 |
| Completed | Pharmacokinetic, Immunogenicity, and Safety Evaluation of Pegfilgrastim TPI-120 in Healthy Adults NCT07416955 | Kashiv BioSciences, LLC | Phase 1 |
| Recruiting | A Phase 1 Study of S-4321 NCT06877611 | Seismic Therapeutic AU Pty Ltd | Phase 1 |
| Active Not Recruiting | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single Ascending Subcuta NCT06895343 | AbbVie | Phase 1 |
| Not Yet Recruiting | Study of SLN12140 in Healthy Adult Participants NCT06945445 | Linno Pharmaceuticals, Inc. | Phase 1 |
| Completed | LC-Plasma for Preventing URTIs and Reducing Symptoms NCT06827327 | RDC Clinical Pty Ltd | Phase 3 |
| Completed | A Study to Assess the Relative Bioavailability of Oral Tavapadon in Healthy Adult Participants NCT06895356 | AbbVie | Phase 1 |
| Completed | A Study to Assess How Food Affects the Movement of Oral ABBV-101 Through the Body of Healthy Adult Participant NCT06887010 | AbbVie | Phase 1 |
| Recruiting | ENX-205 SAD/PET Study in Healthy Adults NCT07253246 | Engrail Therapeutics INC | Phase 1 |
| Recruiting | Effect of LIMICOL®-NG on Plasma LDL-cholesterol Concentration in Subjects with Moderate Hypercholesterolemia NCT06894251 | Institut Pasteur de Lille | N/A |
| Completed | A Varegacestat Hepatic Impairment Study NCT06841315 | Immunome, Inc. | Phase 1 |
| Active Not Recruiting | Phase 1 Safety and Tolerability Study of ALN-F1202 in Healthy Adults NCT06669234 | Regeneron Pharmaceuticals | Phase 1 |
| Completed | Phase 1 Safety and Tolerability Study of REGN9533 in Healthy Adults NCT06665828 | Regeneron Pharmaceuticals | Phase 1 |
| Recruiting | Exploring the Role of the Prefrontal Cortex in Decision-Making NCT07080489 | University of Bern | N/A |
| Completed | A Study of Subcutaneous DR-01 in Healthy Volunteers NCT06766864 | Dren Bio | Phase 1 |
| Recruiting | A Phase 1 Study of S-1117 NCT06828393 | Seismic Therapeutic AU Pty Ltd | Phase 1 |
| Recruiting | Avocado and Postprandial Responses NCT06818032 | University of Vermont Medical Center | N/A |
| Not Yet Recruiting | Measurement of the Optic Nerve Diameter in Different Healthcare Operators NCT06830460 | University Magna Graecia | N/A |
| Active Not Recruiting | A Study to Assess the Relative Bioavailability of Oral ABBV-932 in Healthy Adult Participants NCT06849791 | AbbVie | Phase 1 |
| Completed | A Phase 1 Mass Balance Study of Varegacestat NCT06845852 | Immunome, Inc. | Phase 1 |
| Completed | A Cardiac Liability Study of Varegacestat in Healthy Participants NCT06855264 | Immunome, Inc. | Phase 1 |
| Completed | Clinical Trial Investigating the Effects of EP395 Following an Inhaled Endotoxin Challenge in Healthy Adults NCT06677918 | EpiEndo Pharmaceuticals | Phase 1 |
| Recruiting | Effect of Acute Hypoxia on Renal Hemodynamic in Healthy Volunteers, Patients With Diabetes and Patients With D NCT06846034 | Poitiers University Hospital | N/A |
| Completed | A Study to Determine the Biodistribution, Safety, and Tolerability of a Microdose of Radiolabeled BIIB080 Co-a NCT06454721 | Biogen | Phase 1 |
| Recruiting | Physiological and Psychological Profiles NCT07026383 | Princess Nourah Bint Abdulrahman University | — |
| Active Not Recruiting | A Study to Assess the Adverse Events and How Subcutaneous (SC) Injections and Intravenous (IV) Infusions of AB NCT06774313 | AbbVie | Phase 1 |
| Enrolling By Invitation | An Investigational Study Examining the Cross-Validation of QbMobile in ADHD and Normative Populations NCT07220330 | Qbtech AB | — |
| Completed | A Study to Assess the Safety of ARGX-109 in Healthy Volunteers NCT06799416 | argenx | Phase 1 |
| Active Not Recruiting | A Multi-part Study of ALG-000184 to Evaluate Safety, Tolerability, Pharmacokinetics and Drug-drug Interaction NCT06672900 | Aligos Therapeutics | Phase 1 |
| Completed | SHORT-term Effects of GLucagon-like Peptide One on BonE NCT06722560 | Odense University Hospital | N/A |
| Recruiting | Phosphatidylethanol and Other Ethanol Consumption Markers NCT06747364 | The University of Texas Health Science Center at San Antonio | N/A |
| Recruiting | Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination NCT06733675 | Basilea Pharmaceutica | Phase 1 |
| Completed | A Study to Find Out How Litifilimab is Processed in the Body in Healthy Participants When Given Under the Skin NCT06741657 | Biogen | Phase 1 |
| Recruiting | Subcutaneously Administered MD-18 for the Treatment of Obesity and Diabetes NCT06739707 | Cohen Global, Ltd. | Phase 1 |
| Completed | A Study to Evaluate the Bioavailability and Food Effects of Oral Venetoclax New Tablet Formulation 2.0 in Heal NCT06742086 | AbbVie | Phase 1 |
| Recruiting | Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics NCT06624137 | Yale University | — |
| Completed | Safety, Tolerability, and Dose Response of VNA-318 in Healthy Males NCT06721091 | VANDRIA | Phase 1 |
| Completed | A Study to Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C]-EDG-7500 NCT06738836 | Edgewise Therapeutics, Inc. | Phase 1 |
| Not Yet Recruiting | TVNS and Upper GI Motility NCT06700200 | Maastricht University Medical Center | N/A |
| Recruiting | Relative Bioavailability of NX-5948 Tablets vs Capsules and the Effect of Covariates on the PK of NX-5948 Tabl NCT06717269 | Nurix Therapeutics, Inc. | Phase 1 |
| Completed | Comparison of Diclofenac Systemic Exposure From Two Different Products (AMZ001 and Diclofenac Diethylammonium NCT06729073 | Amzell | Phase 1 |
| Completed | A Single Dose Study to Assess Adverse Events and How Oral Icalcaprant Moves Through the Body in Healthy Adult NCT06722417 | AbbVie | Phase 1 |
| Completed | Safety and PK of Multiple Doses of MT1988 NCT06728176 | Monument Therapeutics Limited | Phase 1 |
| Completed | Behavioral Indicators of Pain Representation NCT06669767 | Universite de Picardie Jules Verne | — |
| Completed | A Study to Assess Change in How Oral Icalcaprant With Itraconazole Moves Through the Body in Healthy Adult Par NCT06722430 | AbbVie | Phase 1 |
| Completed | A Study to Assess the Safety, Tolerability, and Interactions of ABBV-CLS-616 Oral Tablets in Healthy Adult Par NCT06698926 | AbbVie | Phase 1 |
| Completed | A Phase 1 Study to Examine the Effects of Itraconazole After Single Dose Administration of Varegacestat (AL102 NCT06677996 | Immunome, Inc. | Phase 1 |
| Completed | Perceived Satiety and Consumer Sensory Acceptance of Functional Foods Enriched With Edible Insect and Plant Pr NCT07181408 | University of Turin, Italy | N/A |
| Completed | Phase 1 Study Evaluating PALI-2108 in Healthy Volunteers and Ulcerative Colitis Patients. NCT06663605 | Palisade Bio | Phase 1 |
| Completed | Absolute Bioavailability, Absorption, Metabolism, Excretion, and Mass Balance Study of [14C] NX-5948 NCT06691828 | Nurix Therapeutics, Inc. | Phase 1 |
| Recruiting | A Study to Assess How the Drug Moves Through the Body, Adverse Events, and Tolerability of Oral ABBV-722 Capsu NCT06673238 | AbbVie | Phase 1 |
| Completed | Serum Ferritin Concentration in Kenyan Women and Their Preschool Children at Which the Body Begins to Upregula NCT06655909 | Isabelle Herter-Aeberli | N/A |
| Completed | A Phase I PK Study of Balcinrenone/Dapagliflozin in Healthy Chinese Participants NCT06651021 | AstraZeneca | Phase 1 |
| Completed | A Study to Find Out How BIIB141 (Omaveloxolone) Moves From the Blood Into the Breastmilk of Healthy Women Who NCT06612879 | Biogen | Phase 1 |
| Completed | A Study to Find Out How Different Forms of BIIB091 is Processed in The Body With and Without Food in Healthy P NCT06640933 | Biogen | Phase 1 |
| Recruiting | Food (Poly)Phenol Metabotypes and Beta-cell Mass and Function. NCT06888167 | Azienda Ospedaliero-Universitaria di Parma | N/A |
| Completed | Comparison of Sacral Interface Pressure in Healthy Volunteers on Two Dynamic Pressure-Prevention Support Surfa NCT06661954 | University of Alabama at Birmingham | N/A |
| Completed | A Study to Evaluate Adverse Events and How the Drug Moves Through the Body From Subcutaneous (SC) and Intraven NCT06632938 | AbbVie | Phase 1 |
| Not Yet Recruiting | Bioequivalence Study of Dabigatran Etexilate Capsules 150 mg in Healthy Thai Volunteers Under Fasting Conditio NCT06441916 | International Bio service | Phase 1 |
| Unknown | Bioequivalence Study of Generic Celecoxib 200 mg Capsules NCT06337422 | International Bio service | Phase 1 |
| Terminated | A Study to Assess Multiple Ascending Dose, Drug-Drug Interaction, and Asian Pharmacokinetic Study of ABBV-1088 NCT06579300 | AbbVie | Phase 1 |
| Completed | A Study to Find Out How Multiple Doses of BIIB091 Affect the Electrical Activity of the Heart in Healthy Parti NCT06574828 | Biogen | Phase 1 |
| Not Yet Recruiting | Bioequivalence Study of Apixaban 5 mg Film-coated Tablets in Healthy Thai Volunteers NCT06388239 | International Bio service | Phase 1 |
| Recruiting | Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose NCT06223555 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | N/A |
| Completed | Phase I PK Study of Budesonide/Albuterol Delivered From PT027 in Healthy Chinese Participants. NCT06514157 | AstraZeneca | Phase 1 |
| Unknown | Bioequivalence Study of Simvastatin 40 mg Film-coated Tablets in Healthy Thai Volunteers NCT06178640 | International Bio service | Phase 1 |
| Active Not Recruiting | A Study of SGB-9768 in Adult Healthy Volunteers NCT06501573 | Suzhou Sanegene Bio Inc. | Phase 1 |
| Unknown | Bioequivalence Study of Diacerein 50 mg Capsule in Healthy Thai Volunteers NCT06308068 | International Bio service | Phase 1 |
| Unknown | Bioequivalence Study of Empagliflozin 25 mg Film-coated Tablets in Healthy Thai Volunteers NCT06337409 | International Bio service | Phase 1 |
| Recruiting | Smartphone Addiction and Isometric Strength of Rotator Cuff Muscles NCT06633081 | Cairo University | — |
| Completed | An Investigational Study to Evaluate the Cardiac Safety Assessment (TQTc Study) of ESK-001 NCT07378579 | Alumis Inc | Phase 1 |
| Recruiting | A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers NCT06082323 | Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. | Phase 1 |
| Active Not Recruiting | Predictive Cardio-Metabolic Trascrictomics Trajectories In The Barilla Offspring Follow-Up Study NCT06876818 | Azienda Ospedaliero-Universitaria di Parma | — |
| Unknown | The Bioequivalence Study of Fixed-dose Combination of Vildagliptin and Metformin HCI 50/1000 mg FCT Under Fed NCT06244407 | International Bio service | Phase 1 |
| Completed | Study of [14C] ABBV-CLS-7262 in Healthy Male Volunteers Following Single Oral Dose Administration NCT06425003 | Calico Life Sciences LLC | Phase 1 |
| Unknown | Bioequivalence Study of Amlodipine/Valsartan 10/160 mg Film Coated Tablets NCT06193044 | International Bio service | Phase 1 |
| Recruiting | Mapping the Effect of (neuro)inflammation on Stress Sensitivity in the Brain of Healthy Men NCT06620679 | Universitaire Ziekenhuizen KU Leuven | N/A |
| Unknown | The Bioequivalence Study of Linagliptin 5 mg Film-coated Tablet in Healthy Thai Volunteers NCT06243809 | International Bio service | Phase 1 |
| Completed | An Investigational Study to Evaluate the Safety and Tolerability of Single and Multiple Ascending Doses of A-0 NCT07442149 | Alumis Inc | Phase 1 |
| Completed | A Study to Compare the Effect of Omadacycline Versus Moxifloxacin in Healthy Adult Volunteers NCT06462326 | Zai Lab (Hong Kong), Ltd. | Phase 1 |
| Completed | A Study to Look at How a Single Oral Dose of Carbon-14-Labelled [14C] BIIB091 Moves Through and is Processed b NCT06311786 | Biogen | Phase 1 |
| Completed | Single Ascending Dose, Multiple Ascending Dose, Food Effect Study NCT06938204 | Innovo Therapeutics, Inc. | Phase 1 |
| Completed | The Accuracy and Efficacy of AI-driven tVNS Algorithm NCT05215756 | Queen Mary University of London | N/A |
| Unknown | Bioequivalence Study of Generic Leflunomide 20 mg Film-coated Tablets and Reference Product Under Fasting Cond NCT06228443 | International Bio service | Phase 1 |
| Completed | Comparative Bioavailability Study of Tablet and Granule Formulations of ADC189 and the Study of Ultra-high Dos NCT06428903 | Jiaxing AnDiCon Biotech Co.,Ltd | Phase 1 |
| Unknown | The Bioequivalence Study of Alfuzosin 10 mg Prolong-released Tablets Under Fed Conditions NCT06228339 | International Bio service | Phase 1 |
| Completed | Cardiorespiratory Adaptations to High-Intensity Inter-val Training in Young Boxers NCT07024290 | Princess Nourah Bint Abdulrahman University | N/A |
| Completed | A Study to Assess the Mass Balance of [14C] ABBV-552 in Healthy Male Participants Following Single Oral Dose A NCT06278766 | AbbVie | Phase 1 |
| Unknown | The Bioequivalence Study of Acyclovir 800 mg Tablet in Healthy Thai Volunteers Under Fasting Conditions NCT06228430 | International Bio service | Phase 1 |
| Completed | A Study to Assess the Potential for Gastric-pH Dependent Drug-Drug Interactions of BIIB122 With a Proton Pump NCT06264440 | Biogen | Phase 1 |
| Active Not Recruiting | NTI164 Human PK Study NCT06713447 | Fenix Innovation Group | Phase 1 |
| Completed | A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single NCT06385158 | Changchun GeneScience Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | A Study to Evaluate the Pharmacokinetics, Safety and Immunogenicity of BIIB800 Subcutaneously (SC) Compared to NCT06262477 | Biogen | Phase 1 |
| Completed | Diagnostic Performance of Gastric Ultrasound in Children NCT06079268 | Hospices Civils de Lyon | N/A |
| Completed | Comparison of a Torso-Based Derived 6-Lead Electrocardiogram (ECG) Device With Standard 12-Lead Electrocardiog NCT07277374 | Haydarpasa Numune Training and Research Hospital | — |
| Completed | CampETEC Hyperimmune Bovine Colostrum (HBC) NCT06122870 | Johns Hopkins Bloomberg School of Public Health | Phase 1 |
| Completed | Bioequivalence and Food Effect Bioavailability Study of Lumacaftor Film-Coated Tablets NCT05968612 | Qanatpharma Canada LTD | Phase 1 |
| Terminated | Food Intake and IgA Microbiota in Anorexia Nervosa NCT05842343 | Centre Hospitalier Universitaire de Saint Etienne | N/A |
| Completed | A Study of DISC-3405 in Healthy Volunteers NCT06050915 | Disc Medicine, Inc | Phase 1 |
| Completed | Investigate the PK, Safety, and Tolerability After Single and Multiple Dose Daridorexant in Chinese Healthy Su NCT06326723 | Jiangsu Simcere Pharmaceutical Co., Ltd. | Phase 1 |
| Unknown | Normal Reference Values in Han Adults of Skin Thickness and Blood Flow by High-frequency Ultrasound NCT06000163 | First Hospital of China Medical University | — |
| Recruiting | Unraveling Active Ingredients of Neurorehabilitation: Investigating Cortical Activity During Task-oriented Exe NCT06826638 | Fondazione Don Carlo Gnocchi Onlus | — |
| Completed | A Study to Assess the Mass Balance of [14C] ABBV-903 in Healthy Male Participants Following Single Oral Dose A NCT05995366 | AbbVie | Phase 1 |
| Completed | Defining a PK and PD Model for Peripheral Analgesia After IV Oxytocin NCT05929339 | Wake Forest University Health Sciences | Phase 2 |
| Completed | A Study to Assess the Intrapulmonary Pharmacokinetics (PK) of SPR719 by Comparing the Plasma, Epithelial Linin NCT05955586 | Spero Therapeutics | Phase 1 |
| Unknown | Normal Reference Values in Han Adults of Extremity Arterial Structure and Hemodynamics by High-frequency Ultra NCT05970926 | First Hospital of China Medical University | — |
| Completed | Safety, Tolerability, and Pharmacokinetics of DD-S052P in Healthy Volunteers NCT07347223 | HLB Science | Phase 1 |
| Completed | A Study to Assess Drug-Drug Interaction Between ABBV-903 and Midazolam in Adult Healthy Volunteers NCT05895266 | AbbVie | Phase 1 |
| Completed | Safety, Tolerability, and Pharmacokinetics of IRL201104 in Healthy Volunteers NCT05921591 | Revolo Biotherapeutics | Phase 1 |
| Completed | A Study to Assess the Relative Bioavailability of Immediate Release Formulations of ABBV-903 in Healthy Adult NCT05836506 | AbbVie | Phase 1 |
| Completed | Study of Bemnifosbuvir in Subjects With Normal and Impaired Hepatic Function NCT05724693 | Atea Pharmaceuticals, Inc. | Phase 1 |
| Completed | Absorption, Metabolism, Excretion and Absolute Bioavailability of EDG-5506 in Healthy Volunteers NCT05730842 | Edgewise Therapeutics, Inc. | Phase 1 |
| Completed | A Trial to Learn if Single Ascending Intravenous (IV) Doses of REGN7508 Are Safe and Well Tolerated, and How i NCT05603195 | Regeneron Pharmaceuticals | Phase 1 |
| Completed | Assess Gastrointestinal Blood Loss After Receiving Aspirin or Aspirin Plus Rivaroxaban in Healthy Adult Partic NCT05546957 | Regeneron Pharmaceuticals | N/A |
| Completed | A Study to Assess Adverse Events and How Single and Multiple Ascending Doses of ABBV-903 Move Through the Body NCT05691699 | AbbVie | Phase 1 |
| Completed | A Human Tick Kill Study to Investigate the Safety, Tolerability, and Whole Blood Concentration of TP-05 NCT05387083 | Tarsus Pharmaceuticals, Inc. | Phase 2 |
| Completed | A Phase I Study of GFH312 in Healthy Chinese Subjects NCT05991362 | Zhejiang Genfleet Therapeutics Co., Ltd. | Phase 1 |
| Completed | Pharmacokinetics and Pharmacodynamics Study of LBS-008 in Healthy Volunteers Aged 50-85 NCT05667688 | RBP4 Pty Ltd | Phase 1 |
| Completed | Study of AT-527 in Subjects With Normal and Impaired Renal Function NCT05618314 | Atea Pharmaceuticals, Inc. | Phase 1 |
| Recruiting | A Prospective, Multi-center Clinical Study to Establish Multi-Cancer Early Detection Platform Through the Anal NCT06231953 | Yonsei University | — |
| Active Not Recruiting | A Study to Learn About the Safety of BIIB115 Injections and How BIIB115 is Processed in the Bodies of Healthy NCT05575011 | Biogen | Phase 1 |
| Completed | A Study to Evaluate the Drug Exposure of Single Ascending Doses of BMS-986369 and the Effect of Food on the BM NCT05350800 | Bristol-Myers Squibb | Phase 1 |
| Completed | Study to Assess Repeated Doses of INDV-2000 in Healthy Volunteers and in Treatment Seeking Individuals With Op NCT04976855 | Indivior Inc. | Phase 1 |
| Completed | Study of a Single Intramuscular Dose of Nirsevimab in the Prevention of Hospitalizations Due to Respiratory Sy NCT05437510 | Sanofi Pasteur, a Sanofi Company | Phase 3 |
| Completed | Human Mass Balance and Biotransformation Study of [14C]Afuresertib NCT05489744 | Laekna Limited | Phase 1 |
| Completed | Effectiveness of Hybrid Learning Mode of Volunteer Training NCT05686291 | Education University of Hong Kong | N/A |
| Completed | Study on the Body Mass Balance and Biotransformation of [14C]-HEC585 NCT05468346 | Sunshine Lake Pharma Co., Ltd. | Phase 1 |
| Completed | Open-label Safety and PK Study of BION-1301 in Japanese Healthy Subjects NCT05508204 | Chinook Therapeutics, Inc. | Phase 1 |
| Completed | Evaluation of Astaxanthin Properties on Anti-fatigue NCT06593535 | China Medical University Hospital | N/A |
| Completed | A First-in-Human Study of QY101 Ointment in Adult Subjects NCT05429177 | E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. | Phase 1 |
| Completed | Study to Assess the Safety and Pharmacokinetics of WP1122 in Healthy Volunteers NCT05195723 | Moleculin Biotech, Inc. | Phase 1 |
| Completed | A Study to Investigate the Effects of Brensocatib on QT Interval in Healthy Participants NCT05355935 | Insmed Incorporated | Phase 1 |
| Unknown | Evaluation of the Immunogenicity and Safety BBIBP-CorV Vaccine for COVID-19 in Adults in Guinea NCT05409300 | ANRS, Emerging Infectious Diseases | Phase 2 |
| Completed | A Single and Multiple Dosing Study Targeting Biparatopic Antibody CD38 in Healthy Volunteers NCT05215912 | TeneoFour Inc. | Phase 1 |
| Completed | A Study to Investigate the Absolute Bioavailability, Absorption, Metabolism, Distribution and Excretion of [14 NCT05419401 | AstraZeneca | Phase 1 |
| Completed | OrthoEvidence Trial Assessing Japanese Knowledge Updates NCT05250622 | McMaster University | N/A |
| Completed | A Study to Assess the Effect of Erythromycin on the Test Medicine (SAR443820) When Given Orally as Tablets to NCT05797753 | Sanofi | Phase 1 |
| Completed | A Study to See How BIIB122 Works in the Human Body, and to Evaluate it's Safety, and Tolerability in Healthy A NCT05229562 | Biogen | Phase 1 |
| Completed | Tractography and Diffusion Tensor Imaging of the Human Spinal Cord in Healthy Subjects : Anatomical Atlas NCT05079945 | Hospices Civils de Lyon | N/A |
| Completed | A Study to Assess the Pharmacokinetic (PK) Comparability of 2 Fixed Subcutaneous (SC) Doses of Aducanumab (BII NCT05216887 | Biogen | Phase 1 |
| Completed | Proof of Mechanism Study to Evaluate Binding of Alfa-synuclein NCT05274568 | Invicro | Phase 1 |
| Completed | A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics, With Target Occupancy Study of BIIB113 in NCT05195008 | Biogen | Phase 1 |
| Withdrawn | 3D Free-Breathing Multi-echo Acquisition for Whole-body Water/Fat Separation NCT05100927 | Milton S. Hershey Medical Center | — |
| Completed | A Single-volunteer Study of Immune Response Following OTS-412 Vaccinia Virus Systemic Injection(Self-experimen NCT07302945 | Bionoxx Inc. | EARLY_Phase 1 |
| Withdrawn | A Phase 1 Study of PTX-35 in Healthy Volunteers NCT05116969 | Heat Biologics | Phase 1 |
| Completed | A Study to Evaluate Safety and Pharmacokinetics of BIIB104 in Healthy Japanese and Non-Japanese Participants NCT05148481 | Biogen | Phase 1 |
| Completed | Safety Evaluation of KX01 Ointment 1% in Japanese Healthy Male Subjects NCT05245578 | PharmaEssentia | Phase 1 |
| Completed | Safety, Tolerability, and Pharmacokinetics of ASC43F, a Fixed Dose Combination Tablet in Healthy Subjects NCT05118516 | Gannex Pharma Co., Ltd. | Phase 1 |
| Completed | Evaluating the Safety and Relative Bioavailability of Three SPN-817 Treatments (A, B and C) in Healthy Adult S NCT05102552 | Supernus Pharmaceuticals, Inc. | EARLY_Phase 1 |
| Completed | Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Single and Repeated Doses of SAR444336 in Hea NCT05876767 | Sanofi | Phase 1 |
| Recruiting | Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases NCT05078905 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | A Study to Evaluate the Safety and Tolerability of AZD7442 in Healthy Chinese Adults NCT05437289 | AstraZeneca | Phase 1 |
| Completed | Study of SAGE-904 Using a Ketamine Challenge to Evaluate Electrophysiology, Safety, Tolerability, and Pharmaco NCT05049343 | Supernus Pharmaceuticals, Inc. | Phase 1 |
| Completed | Pharmacokinetics, Immunogenicity, Safety and Tolerability of MEDI3506 in Health Chinese Participants NCT05070312 | AstraZeneca | Phase 1 |
| Completed | The Safety and Pharmacokinetics Study of TAKC-02 Inhalation Solution in Healthy Adult Males. NCT05018533 | TAK-Circulator Co. | Phase 1 |
| Completed | Study to Evaluate the Safety, Tolerability, PK and PD of DISC-0974 in Healthy Subjects NCT04999527 | Disc Medicine, Inc | Phase 1 |
| Completed | A Study to Evaluate the Pharmacokinetics and Safety of YHD1119 in Subjects With Renal Impairment and Healthy S NCT05012436 | Yuhan Corporation | Phase 1 |
| Completed | Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP2105 to RLD2104 in Healthy Volunteers NCT04975711 | Hanmi Pharmaceutical Company Limited | Phase 1 |
| Completed | MT1013 Clinical TRIAL In Healthy Subject NCT04783090 | Shaanxi Micot Pharmaceutical Technology Co., Ltd. | Phase 1 |
| Completed | Occupancy of Adenosine A2A Receptors Using the PET Radiotracer [18F]MNI-444 NCT05009199 | Invicro | Phase 1 |
| Unknown | Study Developed to Evaluate the Effect of ANG-3777 on QT/QTc Interval NCT04898907 | Angion Biomedica Corp | Phase 1 |
| Completed | Study of the Absorption, Metabolism, and Excretion of [14C]-Ecopipam in Healthy Male Subjects NCT04881955 | Emalex Biosciences Inc. | Phase 1 |
| Completed | Emotional, Social, Cognitive and Behavioral Sequalae of the COVID-19 Pandemic NCT04823988 | National Institute of Mental Health (NIMH) | — |
| Completed | A Study to Assess the Bioequivalence of Fixed Dose Combination of Dapagliflozin/Metformin XR Relative to Co-ad NCT04856007 | AstraZeneca | Phase 1 |
| Completed | A Drug-Drug Interaction Study Between PF-06882961 and PF-06865571 in Healthy Adult Participants and Overweight NCT04839393 | Pfizer | Phase 1 |
| Completed | A Single and Multiple Ascending Dose Trial of KT-474 in Healthy Adult Volunteers and Patients With Atopic Derm NCT04772885 | Kymera Therapeutics, Inc. | Phase 1 |
| Completed | Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation, and Gastric Emptying in Healthy Vo NCT04849559 | Vanda Pharmaceuticals | Phase 1 / Phase 2 |
| Completed | Safety and PK of Repeated Doses of IRL201104 in Healthy Volunteers NCT04748536 | Revolo Biotherapeutics | Phase 1 |
| Completed | A Phase 1 SAD/MAD Study of RLS-0071 in Healthy Volunteers in Support of a COVID-19 Development Program NCT05298787 | ReAlta Life Sciences, Inc. | Phase 1 |
| Completed | Metabolism and Excretion of [14C]CC-90001 in Healthy Male Subjects NCT04655898 | Celgene | Phase 1 |
| Terminated | Ascending Dose Study of the Safety and Tolerability of REGN6490 in Healthy Volunteers NCT04616079 | Regeneron Pharmaceuticals | Phase 1 |
| Terminated | Study of the Safety, Tolerability, and Pharmacokinetics of REGN6490 in Healthy Japanese Adult Volunteers NCT04616105 | Regeneron Pharmaceuticals | Phase 1 |
| Completed | Study in Healthy Adults to Quantify Lung Deposition and Distribution of Radio-labelled S-770108 Inhalation Pow NCT04631354 | Shionogi | Phase 1 |
| Completed | LTA Assessement Using Aggregometer TA-8V (Stago®) NCT04269603 | Hospices Civils de Lyon | N/A |
| Completed | A Single and Multiple Dose Study of Lemborexant in Healthy Chinese Participants NCT04555733 | Eisai Co., Ltd. | Phase 1 |
| Active Not Recruiting | Effects of a Multi-strain Oral Probiotic on the Vaginal Microbiota Composition in Healthy Women and Women with NCT06592976 | University of Roma La Sapienza | N/A |
| Completed | A Study to Assess Safety, Tolerability, and PK of EDG-5506 in Healthy Volunteers and Becker Muscular Dystrophy NCT04585464 | Edgewise Therapeutics, Inc. | Phase 1 |
| Completed | A Study of Ralinepag in Healthy Chinese Adult Subjects NCT04613999 | Everstar Medicines (Shanghai) Limited | Phase 1 |
| Completed | A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose and Multiple Doses NCT04461483 | Takeda | Phase 1 |
| Completed | A Study to Evaluate the Pharmacokinetics of Single Oral Doses of Ozanimod in Healthy Adult Chinese Subjects NCT04211558 | Celgene | Phase 1 |
| Completed | Study of a Single Subcutaneous Dose of Pozelimab Produced From Two Different Manufacturing Processes in Health NCT04491838 | Regeneron Pharmaceuticals | Phase 1 |
| Completed | Study To Characterize Mass Balance, Absolute Bioavailability, Fraction Absorbed And Pharmacokinetics Of 14C PF NCT04495140 | Pfizer | Phase 1 |
| Completed | Effect of Food on the Pharmacokinetics of ASTX660 in Healthy Volunteers NCT04479800 | Astex Pharmaceuticals, Inc. | Phase 1 |
| Completed | A Study of TAK-951 in Healthy Adults NCT04486950 | Takeda | Phase 1 |
| Completed | Renal Impairment Study of PF-06700841 NCT04260464 | Pfizer | Phase 1 |
| Completed | A Study to Investigate the Effect of CYP3A4 Inhibition on the Single Dose Pharmacokinetics of ASTX660 and the NCT04411030 | Astex Pharmaceuticals, Inc. | Phase 1 |
| Completed | Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP1802 to HGP1705 in Healthy Volunteers NCT04324905 | Hanmi Pharmaceutical Company Limited | Phase 1 |
| Completed | Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers NCT04339790 | National Institute of Mental Health (NIMH) | — |
| Withdrawn | Brain Effect of Vagal Nerve Stimulation at Rest and Pain NCT04282226 | Queen Mary University of London | N/A |
| Completed | A Study to Evaluate Potential Cytochrome P450 and Transporter Protein Interactions With CC-99677 NCT04268394 | Celgene | Phase 1 |
| Completed | A Study to Evaluate the Metabolism and Excretion of [14C]-CC-90009 in Healthy Male Subjects NCT04297124 | Celgene | Phase 1 |
| Active Not Recruiting | Neuroinflammation Imaging in AD NCT04274998 | University of Pennsylvania | EARLY_Phase 1 |
| Completed | BE Study of Two Formulations of Rivaroxaban 2.5 mg in Healthy Subjects NCT05418803 | Yuhan Corporation | Phase 1 |
| Completed | Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Subjects NCT04204629 | Hanmi Pharmaceutical Company Limited | Phase 1 |
| Completed | To Study the Pharmacokinetic and Cardiovascular Effects of Propofol With Respect to Pharmacogenetics in Pakist NCT05383534 | Riphah International University | — |
| Completed | Pharmacokinetic Study of KHK7580 in Healthy Adult Volunteers NCT04206657 | Kyowa Kirin Co., Ltd. | Phase 1 |
| Completed | Clinical Trial to Evaluate the Safety and Pharmacokinetics of YHP1903 in Healthy Volunteers NCT04225052 | Yuhan Corporation | Phase 1 |
| Completed | Tracking Information Flow in the Brain NCT04175119 | Hospices Civils de Lyon | N/A |
| Completed | Inspiratory Flow Parameters With Placebo Easyhaler and Placebo HandiHaler NCT04147572 | Orion Corporation, Orion Pharma | N/A |
| Completed | Pharmacokinetics and Safety of PBK-1801 After Single Oral Administration in Healthy Korean Women NCT04418388 | Pharmbio Korea Co., Ltd. | Phase 1 |
| Completed | Relative Bioavailability and PPI Effects of CC-92480 Test and Reference Formulations in Healthy Subjects NCT04211545 | Celgene | Phase 1 |
| Completed | Safety, Blood Levels and Effects of AUT00201 NCT04158453 | Autifony Therapeutics Limited | Phase 1 |
| Completed | Evaluation of Safety, Tolerability, Pharmacokinetics, Drug-Drug and Food Interactions of Single and Multiple D NCT04147715 | Shionogi | Phase 1 |
| Completed | Systems Analyses of the Immune Response to the Seasonal Influenza Vaccine NCT04025580 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Safety, Pharmacokinetic, and Pharmacodynamic Study of TS-142 in Healthy Subjects NCT04087707 | Taisho Pharmaceutical Co., Ltd. | Phase 2 |
| Active Not Recruiting | Evaluation of Neuroinflammation in Parkinson's Disease Using 18F-NOS PET/CT NCT04062526 | University of Pennsylvania | EARLY_Phase 1 |
| Unknown | Pharmacokinetic Study of SH-1028 Tablets in Healthy Subjects Under Fasting and Fed Conditions NCT03973632 | Nanjing Sanhome Pharmaceutical, Co., Ltd. | Phase 1 |
| Unknown | A Food-Effect Study of SHC014748M in Healthy Subjects NCT04006860 | Nanjing Sanhome Pharmaceutical, Co., Ltd. | Phase 1 |
| Completed | Study to Assess the Pharmacokinetics, Safety and Tolerability of Baloxavir Marboxil in Healthy Chinese Partici NCT03959332 | Hoffmann-La Roche | N/A |
| Completed | Comparision of Pharmacokinetics(PK) and Pharmacodynamics(PD) of Biocon Insulin R and Humulin® R NCT04022317 | Biocon Limited | Phase 1 |
| Completed | Comparison of Pharmacokinetic (PK) and Pharmacodynamic(PD) of Biocon Insulin 70/30 and Humulin® 70/30 NCT04022291 | Biocon Limited | Phase 1 |
| Completed | Comparision of Pharmacokinetic and Pharmacodynamic of Biocon Insulin N and Humulin® N NCT04022304 | Biocon Limited | Phase 1 |
| Recruiting | Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors NCT04354064 | Washington University School of Medicine | — |
| Completed | A Study to Assess the Relative Bioavailability of Gilteritinib Following a Single Dose of Gilteritinib Mini-ta NCT03964038 | Astellas Pharma Global Development, Inc. | Phase 1 |
| Completed | A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of BIIB091, a Bruton's Tyrosine Kinase (BTK NCT03943056 | Biogen | Phase 1 |
| Recruiting | Optimization of a Non-invasive Electrophysiological Method for Studying the Functionality of Auditory Nerve Fi NCT04198909 | University Hospital, Clermont-Ferrand | N/A |
| Completed | THE EFFECT OF MULTIPLE DOSES OF PF-06835919 ON THE PHARMACOKINETICS OF A SINGLE ORAL MIDAZOLAM DOSE IN HEALTHY NCT03916406 | Pfizer | Phase 1 |
| Recruiting | Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy Volunteers NCT03878121 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | A Study to Assess the Safety of Experimental Medication BMS986165 in Participants With Normal Kidney Function NCT03890770 | Bristol-Myers Squibb | Phase 1 |